Results 321 to 330 of about 4,732,777 (361)
Some of the next articles are maybe not open access.

Neoadjuvant therapy for resectable melanoma

Clinical & Experimental Metastasis
The standard of care for patients with resectable stage III/IV melanoma classically included upfront resection with adjuvant therapy. However, in more recent years, the amount of systemic therapies available for neoadjuvant use for these patients has increased.
Cimarron E. Sharon   +1 more
openaire   +2 more sources

Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes

Annals of Surgical Oncology, 2021
Joseph C. H. Kong   +8 more
semanticscholar   +1 more source

[Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].

Zeitschrift fur Gastroenterologie, 2011
Approximately one third of patients with colorectal cancer (CRC) present with metastases confined to the liver only. In 15 % of these patients the metastases are primarily resectable. After resection of colorectal liver metastases the 5-year survival rate is 25 - 40 %. The EORTC trial of Nordlinger et al.
D, Arnold   +5 more
openaire   +1 more source

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

The Lancet Oncology, 2018
C. Denkert   +26 more
semanticscholar   +1 more source

NEOADJUVANT THERAPY

2012
Laurie Kirstein   +2 more
openaire   +2 more sources

Radiation therapy‐associated toxicity: Etiology, management, and prevention

Ca-A Cancer Journal for Clinicians, 2021
Kyle Wang
exaly  

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

Future direction of total neoadjuvant therapy for locally advanced rectal cancer

Nature reviews: Gastroenterology & hepatology
Y. Kagawa   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy